John Olichney

John Olichney is a Professor at the University of California, Davis, specializing in behavioral neurology with expertise in cognitive disorders and neurodegenerative diseases including Alzheimer's disease. Board-certified in behavioral neurology, he has served on the Bioethics Committee (2009-2022) and Institutional Review Board (2010-2011).

His educational background includes:

• M.D. from the University of California, Irvine (1988)
• B.A. in Neurobiology with honors from UC Berkeley (1983)

Dr. Olichney's research focuses on electrophysiological and neuroimaging mechanisms of language and memory in neurodegenerative disorders. His laboratory develops biomarkers for early detection of Alzheimer's disease using event-related potentials, EEG oscillations, and neuroimaging techniques. Key interests include cognitive biomarkers, memory impairment diagnostics, and neural correlates of language processing in aging populations.

Analysis of his recent publications reveals a consistent emphasis on electrophysiological biomarkers for Alzheimer's disease progression, with significant contributions to P300 and N400 event-related potential research. His work bridges basic electrophysiology with clinical applications, particularly in predicting cognitive decline and validating diagnostic tools across diverse populations.

His scientific awards include:

• NARSAD Young Investigator Award (2000-2003)
• NARSAD Young Investigator Award (1997-1999)
• NIH Physician Scientist Award (National Institute on Aging) (1995-2001)
• Honors in Neurology Research (1987)

Dr. Olichney teaches medical students, residents, and fellows in behavioral neurology and dementia care while mentoring research fellows and graduate students in cognitive neuroscience methods. His NIH-funded research has established critical electrophysiological markers for neurodegenerative disease progression.

He directs the Cognitive Electrophysiology and Neuroimaging Lab, which integrates EEG, ERP, and neuroimaging techniques to develop sensitive diagnostic tools for memory and language impairments in aging and neurodegenerative conditions.